Results
|
1.
|
|
|
2.
|
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. MedStar authors:
- Atkins, Francis
- Garcia, Carlos
- Van Nostrand, Douglas
Year: 2017
Citation: - Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
Medline publication type:
All authors: - Atkins F, Garcia C, Hobbs RF, Huang K, Plyku D, Sgouros G, Van Nostrand D
|
|
3.
|
Validation of a Simple Thyroid Cancer Dosimetry Model Based on the Fractional Whole-Body Retention at 48 Hours Post-Administration of (131)I. MedStar authors:
- Atkins, Francis
- Burman, Kenneth D
- Moreau, Shari
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Citation: - Thyroid. 25(12):1347-50, 2015 Dec.
Institution:
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
- Medicine/Nuclear Medicine
- Medicine/Nuclear Medicine
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
- Validation Studies
All authors: - Atkins F, Burman K, Moreau S, Van Nostrand D, Wartofsky L
|